TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 14.15%-111.18M | ---- | -62.93%-129.51M | ---- | -567.63%-79.49M | ---- | -213.23%-11.91M | ---- | -61.30%10.52M |
Profit adjustment | ||||||||||
Attributable subsidiary (profit) loss | ---- | 101.53%16K | ---- | 54.91%-1.04M | ---- | -2,390.10%-2.31M | ---- | 352.50%101K | ---- | ---40K |
Impairment and provisions: | ---- | -25.83%17.8M | ---- | --24M | ---- | ---- | ---- | ---- | ---- | 4,350.00%6.32M |
-Impairment of property, plant and equipment (reversal) | ---- | -34.82%3.1M | ---- | --4.76M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,867.61%2.79M |
-Other impairments and provisions | ---- | -23.61%14.7M | ---- | --19.24M | ---- | ---- | ---- | ---- | ---- | --3.53M |
Revaluation surplus: | ---- | 35.34%2.68M | ---- | --1.98M | ---- | ---- | ---- | -46,300.00%-928K | ---- | 99.91%-2K |
-Other fair value changes | ---- | 35.34%2.68M | ---- | --1.98M | ---- | ---- | ---- | -46,300.00%-928K | ---- | 99.91%-2K |
Asset sale loss (gain): | ---- | 756.62%893K | ---- | -13,700.00%-136K | ---- | -93.33%1K | ---- | 101.46%15K | ---- | -4,379.17%-1.03M |
-Loss (gain) from sale of subsidiary company | ---- | -525.89%-701K | ---- | ---112K | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 3,579.17%835K | ---- | -2,500.00%-24K | ---- | -93.33%1K | ---- | 275.00%15K | ---- | -83.33%4K |
-Loss (gain) from selling other assets | ---- | --759K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.03M |
Depreciation and amortization: | ---- | -16.68%33.03M | ---- | 41.92%39.65M | ---- | 108.31%27.93M | ---- | 46.43%13.41M | ---- | 50.48%9.16M |
-Depreciation | ---- | -29.93%8.67M | ---- | 88.38%12.37M | ---- | 105.90%6.57M | ---- | 71.36%3.19M | ---- | 53.67%1.86M |
-Amortization of intangible assets | ---- | 10.99%17.26M | ---- | 78.05%15.55M | ---- | 38.55%8.73M | ---- | 18.27%6.3M | ---- | 85.78%5.33M |
Financial expense | ---- | -7.01%7.48M | ---- | -3.13%8.04M | ---- | 95.34%8.3M | ---- | 4.63%4.25M | ---- | 40.12%4.06M |
Special items | ---- | -50.32%24.54M | ---- | 66.57%49.4M | ---- | 90.13%29.66M | ---- | 609.65%15.6M | ---- | --2.2M |
Operating profit before the change of operating capital | ---- | -224.60%-24.74M | ---- | 52.09%-7.62M | ---- | -177.45%-15.91M | ---- | -34.13%20.54M | ---- | -8.58%31.18M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 63.21%457K | ---- | -69.92%280K |
Accounts receivable (increase)decrease | ---- | -375.96%-36.61M | ---- | 182.14%13.27M | ---- | 78.65%-16.15M | ---- | -93.98%-75.65M | ---- | -827.13%-39M |
Accounts payable increase (decrease) | ---- | -16,393.83%-13.2M | ---- | -99.76%81K | ---- | -21.09%33.58M | ---- | 5.92%42.56M | ---- | 1,380.94%40.18M |
prepayments (increase)decrease | ---- | -406.98%-5.58M | ---- | 49.84%1.82M | ---- | 128.63%1.21M | ---- | -134.77%-4.24M | ---- | 16.66%-1.81M |
Special items for working capital changes | ---- | 246.93%41.69M | ---- | -145.06%-28.37M | ---- | 83.38%-11.58M | ---- | -3,866.79%-69.65M | ---- | 107.81%1.85M |
Cash from business operations | 37.16%-31.95M | -84.60%-38.45M | 34.99%-50.85M | -135.53%-20.83M | -33.04%-78.22M | 89.72%-8.84M | 23.66%-58.8M | -363.04%-85.98M | -319.60%-77.02M | 89.37%32.69M |
Other taxs | 79.54%-151K | 115.83%76K | -44.71%-738K | 84.99%-480K | 76.81%-510K | 11.46%-3.2M | 1.26%-2.2M | 31.07%-3.61M | 44.41%-2.23M | -210.74%-5.24M |
Net cash from operations | 37.77%-32.1M | -80.09%-38.37M | 34.48%-51.59M | -76.97%-21.31M | -29.08%-78.73M | 86.56%-12.04M | 23.03%-61M | -426.39%-89.59M | -254.39%-79.25M | 76.24%27.45M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 166.67%128K | 470.73%234K | 152.63%48K | -69.63%41K | -81.37%19K | -73.68%135K | -67.92%102K | 119.23%513K | 234.74%318K | -64.65%234K |
Loan receivable (increase) decrease | ---- | 167.14%6.13M | 184.34%3.13M | ---9.13M | ---3.71M | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | -62.16%140K | 2,700.00%140K | 12,233.33%370K | --5K | --3K | ---- | ---- | ---- | --2K |
Purchase of fixed assets | -21.27%-1.3M | 32.37%-1.71M | 67.59%-1.07M | 82.63%-2.52M | 72.58%-3.31M | 60.12%-14.53M | -166.80%-12.06M | -64.34%-36.43M | 55.86%-4.52M | 3.23%-22.17M |
Selling intangible assets | ---- | --15K | --15K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of intangible assets | 42.97%-2.19M | 62.83%-15.07M | 77.66%-3.83M | -13.74%-40.54M | -148.91%-17.16M | -172.92%-35.64M | -314.05%-6.89M | -262.68%-13.06M | -91.38%-1.67M | 71.45%-3.6M |
Sale of subsidiaries | ---- | 19,161.54%2.48M | --2.45M | ---13K | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---1.57M | ---1.57M | ---- | ---- | ---- | ---- | ---1.69M | ---- | ---- |
Recovery of cash from investments | ---- | --612K | ---- | ---- | ---- | ---- | ---- | 794.06%28.29M | ---- | -95.55%3.16M |
Cash on investment | ---1.95M | ---- | ---- | ---- | ---- | ---- | ---- | 288.57%2.64M | -2,636.00%-27.36M | 97.26%-1.4M |
Net cash from investment operations | -660.46%-5.31M | 83.13%-8.74M | 97.11%-698K | -3.53%-51.8M | -28.12%-24.16M | -153.51%-50.03M | 43.26%-18.85M | 16.96%-19.74M | -275.33%-33.23M | -60.51%-23.77M |
Net cash before financing | 28.45%-37.41M | 35.56%-47.11M | 49.18%-52.29M | -17.77%-73.1M | -28.85%-102.89M | 43.22%-62.07M | 29.01%-79.85M | -3,068.45%-109.33M | -260.33%-112.48M | 379.56%3.68M |
Cash flow from financing activities | ||||||||||
New borrowing | 10.77%52.02M | 3.19%225.69M | -31.35%46.96M | 59.94%218.71M | -32.73%68.4M | 18.05%136.75M | 87.05%101.68M | 24.06%115.84M | -7.98%54.36M | 26.52%93.37M |
Refund | 7.87%-54.08M | 11.65%-191.35M | -554.78%-58.7M | -81.18%-216.59M | 119.43%12.91M | -25.36%-119.54M | -35.85%-66.44M | -8.88%-95.36M | 0.26%-48.91M | -155.52%-87.59M |
Issuing shares | ---- | 151.09%131.16M | --131.16M | --52.24M | ---- | ---- | ---- | ---- | ---- | --134.62M |
Interest paid - financing | -22.89%-4.04M | -57.89%-10.78M | -208.74%-3.29M | -10.79%-6.83M | 16.88%-1.06M | -44.37%-6.16M | 29.40%-1.28M | -6.59%-4.27M | 31.66%-1.81M | -22.97%-4.01M |
Absorb investment income | ---- | --490K | ---- | ---- | ---- | --9.07M | --9.07M | ---- | ---- | -57.46%4.25M |
Issuance expenses and redemption of securities expenses | ---- | -596.67%-3.77M | ---3.77M | ---541K | ---- | ---- | ---- | ---- | ---- | -707.13%-9.62M |
Pledged bank deposit (increase) decrease | 242.35%1.12M | 114.40%216K | 47.73%-784K | -121.94%-1.5M | 81.47%-1.5M | 624.36%6.84M | -455.00%-8.09M | -47.82%944K | -12.81%2.28M | 133.98%1.81M |
Other items of the financing business | ---- | ---- | -108.00%-3.2M | --36.54M | --40M | ---- | ---- | ---- | ---- | ---- |
Net cash from financing operations | -106.79%-7.23M | 126.20%147.65M | -3.59%106.45M | 542.83%65.27M | 312.47%110.41M | 68.95%10.15M | 566.20%26.77M | -95.39%6.01M | -65.08%4.02M | 5,415.79%130.34M |
Effect of rate | 235.26%1.62M | -342.49%-2.39M | -372.60%-1.19M | 417.04%986K | 447.62%438K | 67.26%-311K | -431.58%-126K | -675.76%-950K | 195.00%38K | -17.50%165K |
Net Cash | -182.42%-44.64M | 1,384.00%100.54M | 619.95%54.16M | 84.92%-7.83M | 114.17%7.52M | 49.75%-51.92M | 51.06%-53.08M | -177.09%-103.32M | -450.32%-108.46M | 4,180.45%134.02M |
Begining period cash | 649.50%113.26M | -31.17%15.11M | -31.17%15.11M | -70.40%21.96M | -70.40%21.96M | -58.43%74.18M | -58.43%74.18M | 303.14%178.45M | 303.14%178.45M | 8.14%44.27M |
Cash at the end | 3.16%70.23M | 649.50%113.26M | 127.57%68.08M | -31.17%15.11M | 42.61%29.92M | -70.40%21.96M | -70.05%20.98M | -58.43%74.18M | 185.64%70.03M | 303.14%178.45M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.